title: Close correlation between development of MODS during the initial 72 h of hospitalization and hospital mortality in severe fever with thrombocytopenia syndrome.
abstract: An emerging infectious disease was identified as severe fever with thrombocytopenia syndrome (SFTS) in central China since late March 2009. We found the patients with SFTS had severe clinical symptoms, and progressed rapidly to multiple organ dysfunction syndrome (MODS) with high fatality rate of 25%-30%. The aim of this study was to assess the significance of risk factors predicting the development of MODS and death in SFTS patients. Consecutive SFTS admissions between May 2009 and September 2011 were analyzed for parameters of organ function during hospitalization using Marshall scoring system for MODS, and platelet counts were recorded on admission and at 24, 48, 72 h and one week after admission. We investigated the kinetics of organ failures and analyzed the association between age, platelet count and development of MODS or death. A total of 92 SFTS patients were enrolled in this study. Among them, 32 patients with dysfunction of over 4 organs were identified, 45% of them died within 72 h, 72% died within 5 days, and 76% died within 7 days after admission. We also found cumulative Marshall score was significantly higher in death patients (11.76±2.05) than in survival patients (4.22±1.98) (P<0.001). In addition, SFTS patients had older age and lower platelet counts in MODS and death groups. Furthermore, we also observed that there was a close correlation between platelet count on admission and Marshall score (P<0.001). High Marshall score, advanced age and lower platelet counts were the main risk factors for the development of MODS, and those factors could predict mortality in SFTS patients, suggesting prompt treatment and close monitoring of severe complications, especially MODS, are of great importance in saving patients' lives.
authors: Department of Infectious Diseases, Huazhong University of Science and Technology, Wuhan, 430022, China.
authors: Sheng-Hua
authors: SH
authors: Jie
authors: Department of Infectious Diseases, Huazhong University of Science and Technology, Wuhan, 430022, China.
authors: Yan
authors: Y
authors: Zhou
authors: Department of Infectious Diseases, Huazhong University of Science and Technology, Wuhan, 430022, China.
authors: Li-Ping
authors: LP
authors: Sun
authors: Center for Stem Cell Research and Application, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China.
authors: Kai-Wei
authors: KW
authors: Liang
authors: Department of Infectious Diseases, Huazhong University of Science and Technology, Wuhan, 430022, China.
authors: Xiao-Ling
authors: XL
authors: Yi
authors: Center for Stem Cell Research and Application, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China. huiyuli26@yahoo.com.cn.
authors: Hui-Yu
authors: HY
authors: Li
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D002681:China; D015897:Comorbidity; D005260:Female; D017052:Hospital Mortality; D006801:Humans; D007902:Length of Stay / Q000706:statistics & numerical data*; D008297:Male; D008875:Middle Aged; D009102:Multiple Organ Failure / Q000401:mortality*; D010217:Phlebotomus Fever / Q000401:mortality*; D018570:Risk Assessment; D013223:Statistics as Topic; D015996:Survival Rate; D013577:Syndrome; D013921:Thrombocytopenia / Q000401:mortality*; D055815:Young Adult
references: Clin Infect Dis. 2012 Jan 15;54(2):249-52
references: 22095565
references: Clin Infect Dis. 1996 Jul;23(1):198
references: 8816164
references: Zhonghua Liu Xing Bing Xue Za Zhi. 2011 Mar;32(3):209-20
references: 21457654
references: Clin Microbiol Rev. 2001 Apr;14(2):296-326
references: 11292640
references: Clin Infect Dis. 2007 Sep 1;45(5):589-93
references: 17682993
references: Clin Infect Dis. 2012 Feb 15;54(4):527-33
references: 22144540
references: JAMA. 2008 Nov 19;300(19):2263-70
references: 19017912
references: Vet Res. 2010 Nov-Dec;41(6):61
references: 21188836
references: J Infect Dis. 1991 Dec;164(6):1119-27
references: 1683355
references: Emerg Infect Dis. 2005 Dec;11(12):1828-34
references: 16485466
references: N Engl J Med. 2011 Apr 21;364(16):1561-3
references: 21410394
references: Thromb Haemost. 2009 Dec;102(6):1030-41
references: 19967132
references: N Engl J Med. 2011 Apr 21;364(16):1523-32
references: 21410387
references: J Infect Dis. 2012 Oct 1;206(7):1095-102
references: 22850122
references: Lancet Infect Dis. 2006 Apr;6(4):203-14
references: 16554245
references: South Med J. 2009 Jun;102(6):620-5
references: 19434035
references: Crit Care Med. 1995 Oct;23(10):1638-52
references: 7587228
references: Antiviral Res. 2003 Jan;57(1-2):101-11
references: 12615306
references: Annu Rev Med. 1999;50:531-45
references: 10073292
references: Clin Infect Dis. 2003 Jun 15;36(12):1613-8
references: 12802764